SelectQuote, Inc. (NYSE:SLQT) Director Acquires $14,480.00 in Stock

SelectQuote, Inc. (NYSE:SLQTGet Free Report) Director Denise L. Devine acquired 4,000 shares of the business’s stock in a transaction on Friday, March 14th. The stock was acquired at an average price of $3.62 per share, with a total value of $14,480.00. Following the acquisition, the director now owns 318,583 shares in the company, valued at $1,153,270.46. The trade was a 1.27 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

SelectQuote Stock Performance

Shares of SLQT stock opened at $3.79 on Friday. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. SelectQuote, Inc. has a 52 week low of $1.48 and a 52 week high of $6.86. The stock has a market capitalization of $651.57 million, a PE ratio of -42.06 and a beta of 1.13. The firm has a 50 day moving average of $4.37 and a two-hundred day moving average of $3.28.

SelectQuote (NYSE:SLQTGet Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. On average, research analysts predict that SelectQuote, Inc. will post -0.07 EPS for the current fiscal year.

Institutional Investors Weigh In On SelectQuote

Institutional investors have recently modified their holdings of the company. Sona Asset Management US LLC purchased a new stake in SelectQuote in the fourth quarter valued at $2,847,000. Portolan Capital Management LLC purchased a new stake in SelectQuote in the fourth quarter valued at $1,873,000. Marshall Wace LLP lifted its position in SelectQuote by 48.1% in the fourth quarter. Marshall Wace LLP now owns 1,052,239 shares of the company’s stock valued at $3,914,000 after acquiring an additional 341,981 shares during the last quarter. AXA S.A. purchased a new stake in SelectQuote in the fourth quarter valued at $1,223,000. Finally, JPMorgan Chase & Co. lifted its position in SelectQuote by 66.8% in the fourth quarter. JPMorgan Chase & Co. now owns 716,784 shares of the company’s stock valued at $2,666,000 after acquiring an additional 287,128 shares during the last quarter. 34.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on SLQT shares. Noble Financial upgraded shares of SelectQuote to a “strong-buy” rating in a report on Wednesday, February 12th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $4.00 target price on shares of SelectQuote in a report on Friday, November 22nd.

Check Out Our Latest Research Report on SelectQuote

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

Further Reading

Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.